Xolair

New treatments on the horizonEmerging therapies are showing impressive efficacy and good tolerability, according to one dermatologist.
Class action suit targets asthma drugXolair (omalizumab), a drug used to treat allergic asthma in adults and children 12 years and older, has been linked to significant health issues such as mini-strokes, heart attacks and blood clots, according to the law firm of Baron and Budd, which has offices in Dallas, Texas, and several other cities.
Asthma drug relieves chronic hivesThe asthma drug omalizumab may provide symptom relief to patients with chronic idiopathic urticaria, results of a recently published study suggest.
FDA Drug Approvals: April 2014FDA actions in brief, fast-track designation, orphan drug designation, first-time generic approvals
FDA approves Xolair for chronic idiopathic urticariaThe Food and Drug Administration has approved Xolair (omalizumab, Novartis) for the treatment of chronic idiopathic urticaria in patients ages 12 and older.
Asthma drug calms chronic urticariaThe asthma medication omalizumab helps to calm chronic urticaria in patients who had failed standard therapy, according to results of a phase 3 study.